Latest Articles
Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11 - The Manila Times
Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11 …
Published: Jan. 8, 2026, 12:53 p.m.
Immunotherapy for Advanced Endometrial Cancer - Banner Health
Immunotherapy for Advanced Endometrial Cancer Banner Health
Published: Jan. 8, 2026, 12:51 p.m.
B.C. Cancer unveils new tool to treat cervical, vaginal and endometrial cancers - CBC
B.C. Cancer unveils new tool to treat cervical, vaginal and endometrial cancers CBC
Published: Jan. 8, 2026, 3:35 a.m.
B.C. Cancer unveils new tool to treat cervical, vaginal and endometrial cancers - Yahoo News Canada
B.C. Cancer unveils new tool to treat cervical, vaginal and endometrial cancers Yahoo News Canada
Published: Jan. 8, 2026, 3:35 a.m.
Endometrial Ablation Market in 2025 Detailed Study Analysis - openPR.com
Endometrial Ablation Market in 2025 Detailed Study Analysis openPR.com
Published: Jan. 7, 2026, 10:40 a.m.
Japan sees rising endometrial, cervical cancer rates among young women - MSN
Japan sees rising endometrial, cervical cancer rates among young women MSN
Published: Jan. 7, 2026, 12:47 a.m.
With Decades of Enduring Howard Stern, Resilient Robin Quivers, 73, Is Fighting Endometrial Cancer & Still Laughing - SurvivorNet
With Decades of Enduring Howard Stern, Resilient Robin Quivers, 73, Is Fighting Endometrial Cancer & Still Laughing SurvivorNet
Published: Jan. 7, 2026, 12:12 a.m.
Japan sees rising endometrial, cervical cancer rates among young women - 毎日新聞
Japan sees rising endometrial, cervical cancer rates among young women 毎日新聞
Published: Jan. 6, 2026, 7:53 a.m.
Using Lenvatinib/Pembrolizumab for Endometrial Cancer in Clinical Practice - Targeted Oncology
Using Lenvatinib/Pembrolizumab for Endometrial Cancer in Clinical Practice Targeted Oncology
Published: Jan. 5, 2026, 1:27 p.m.
Real-World Results for Lenvatinib Plus Pembrolizumab in Endometrial Cancer - Targeted Oncology
Real-World Results for Lenvatinib Plus Pembrolizumab in Endometrial Cancer Targeted Oncology
Published: Jan. 5, 2026, 1:12 p.m.
Link copied to clipboard!